Strides Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE939A01011
NSEID: STAR
BSEID: 532531
View on NSE | View on BSE

INR

1,007.05

11.45 (1.15%)

BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 2.79 lacs

{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,007.05",
    "chg": 11.45,
    "chgp": "1.15%",
    "dir": 1,
    "prev_price": "995.60",
    "mcapval": "9,273.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE939A01011",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "07:10 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "2.79 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Declines 1.58% Amid Mixed Technical Signals and Valuation Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-declines-158-amid-mixed-technical-signals-and-valuation-shifts-4143473",
        "imagepath": "",
        "date": "2026-08-08 16:06:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Positive quarterly results announced; stock closes at ₹1,027.80 (+0.44%)</p>\n                    <p><strong>4 Aug:</strong> Technical momentum shifts to mildly bullish; stock dips to ₹989.70 (-3.71%)</p>\n                    <p><strong>5 Aug:</strong> Technical indicators signal sideways trend; stock falls further to ₹969.05 (-2.09%)</p>\n                    <p><strong>6 Aug:</strong> Mild recovery with technical mixed signals; stock rises to ₹995.60 (+2.74%)</p>\n                    <p><strong>7 Aug:</strong> Technical momentum turns mildly bearish despite price rise; closes at ₹1,007.05 (+1.15%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n   ..."
      },
      {
        "title": "Strides Pharma Science Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-4142736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_mojoScore_4142736.png",
        "date": "2026-08-08 10:10:40",
        "description": "Strides Pharma Science Ltd is currently rated 'Hold' by MarketsMOJO, with this rating last updated on 27 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-amid-mixed-indicators-4140984",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_technicaldot_4140984.png",
        "date": "2026-08-07 08:03:41",
        "description": "Strides Pharma Science Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance, as reflected in recent weekly and monthly technical indicators. Despite a positive day change of 2.74%, the stock’s mixed signals across MACD, RSI, Bollinger Bands, and moving averages suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-amid-mixed-market-signals-4137006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_technicaldot_4137006.png",
        "date": "2026-08-05 08:04:11",
        "description": "Strides Pharma Science Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of bearish and bullish signals across key technical indicators. Despite a recent downgrade in daily price performance, the stock’s year-to-date and longer-term returns continue to outpace the broader Sensex, underscoring its resilience amid sectoral and market fluctuations."
      },
      {
        "title": "Strides Pharma Science Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-shows-mixed-technical-signals-amid-mildly-bullish-momentum-4134841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_technicaldot_4134841.png",
        "date": "2026-08-04 08:06:21",
        "description": "Strides Pharma Science Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors amid a volatile pharmaceutical sector backdrop."
      },
      {
        "title": "Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4132905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_technicaldot_4132905.png",
        "date": "2026-08-03 08:01:56",
        "description": "Strides Pharma Science Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price momentum, the stock’s longer-term outlook remains cautiously optimistic, supported by strong year-to-date returns and a recent upgrade in its Mojo Grade from Sell to Hold."
      },
      {
        "title": "Strides Pharma Science Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-valuation-shifts-signal-renewed-price-attractiveness-4132809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_valuationdot_4132809.png",
        "date": "2026-08-03 08:00:41",
        "description": "Strides Pharma Science Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent 4.67% decline in its share price. This re-rating comes amid a challenging Pharmaceuticals & Biotechnology sector landscape, where Strides’ valuation metrics now stand out favourably against peers and historical averages, signalling potential value for investors."
      },
      {
        "title": "Strides Pharma Science Ltd Reports Positive Quarterly Performance Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-reports-positive-quarterly-performance-amid-market-volatility-4132749",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_fintrenddot_4132749.png",
        "date": "2026-08-03 08:00:11",
        "description": "Strides Pharma Science Ltd has delivered a positive quarterly performance for June 2026, reflecting a shift from a previously very positive to a positive financial trend. Despite a recent downgrade in its Mojo Score from 20 to 10 over the past three months, the company continues to demonstrate robust operational cash flows and improved profitability metrics, signalling resilience in a challenging market environment."
      },
      {
        "title": "Strides Pharma Science Ltd Quality Grade Upgrade Reflects Mixed Fundamental Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-quality-grade-upgrade-reflects-mixed-fundamental-trends-4132736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_qualitydot_4132736.png",
        "date": "2026-08-03 08:00:09",
        "description": "Strides Pharma Science Ltd has seen its quality grade upgraded from below average to average, reflecting notable improvements in its business fundamentals. This shift is underpinned by stronger profitability metrics, manageable debt levels, and enhanced operational efficiency, positioning the small-cap pharmaceutical player more favourably within its sector."
      }
    ],
    "total": 721,
    "sid": "688428",
    "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "03-Aug-2026",
      "details": "Transcript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Aug-2026",
      "details": "Newspaper advertisement - Unaudited Financial Results for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "31-Jul-2026",
      "details": "Strides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12654m Grew 13% YoY; Ex-US Markets Grew 17% YoY",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>50%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Strides Pharma Declines 1.58% Amid Mixed Technical Signals and Valuation Shifts

2026-08-08 16:06:30

Key Events This Week

3 Aug: Positive quarterly results announced; stock closes at ₹1,027.80 (+0.44%)

4 Aug: Technical momentum shifts to mildly bullish; stock dips to ₹989.70 (-3.71%)

5 Aug: Technical indicators signal sideways trend; stock falls further to ₹969.05 (-2.09%)

6 Aug: Mild recovery with technical mixed signals; stock rises to ₹995.60 (+2.74%)

7 Aug: Technical momentum turns mildly bearish despite price rise; closes at ₹1,007.05 (+1.15%)

...

Read full news article

Strides Pharma Science Ltd is Rated Hold

2026-08-08 10:10:40

Strides Pharma Science Ltd is currently rated 'Hold' by MarketsMOJO, with this rating last updated on 27 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-08-07 08:03:41

Strides Pharma Science Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance, as reflected in recent weekly and monthly technical indicators. Despite a positive day change of 2.74%, the stock’s mixed signals across MACD, RSI, Bollinger Bands, and moving averages suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-05 08:04:11

Strides Pharma Science Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of bearish and bullish signals across key technical indicators. Despite a recent downgrade in daily price performance, the stock’s year-to-date and longer-term returns continue to outpace the broader Sensex, underscoring its resilience amid sectoral and market fluctuations.

Read full news article

Strides Pharma Science Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum

2026-08-04 08:06:21

Strides Pharma Science Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors amid a volatile pharmaceutical sector backdrop.

Read full news article

Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-03 08:01:56

Strides Pharma Science Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price momentum, the stock’s longer-term outlook remains cautiously optimistic, supported by strong year-to-date returns and a recent upgrade in its Mojo Grade from Sell to Hold.

Read full news article

Strides Pharma Science Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-03 08:00:41

Strides Pharma Science Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent 4.67% decline in its share price. This re-rating comes amid a challenging Pharmaceuticals & Biotechnology sector landscape, where Strides’ valuation metrics now stand out favourably against peers and historical averages, signalling potential value for investors.

Read full news article

Strides Pharma Science Ltd Reports Positive Quarterly Performance Amid Market Volatility

2026-08-03 08:00:11

Strides Pharma Science Ltd has delivered a positive quarterly performance for June 2026, reflecting a shift from a previously very positive to a positive financial trend. Despite a recent downgrade in its Mojo Score from 20 to 10 over the past three months, the company continues to demonstrate robust operational cash flows and improved profitability metrics, signalling resilience in a challenging market environment.

Read full news article

Strides Pharma Science Ltd Quality Grade Upgrade Reflects Mixed Fundamental Trends

2026-08-03 08:00:09

Strides Pharma Science Ltd has seen its quality grade upgraded from below average to average, reflecting notable improvements in its business fundamentals. This shift is underpinned by stronger profitability metrics, manageable debt levels, and enhanced operational efficiency, positioning the small-cap pharmaceutical player more favourably within its sector.